IDEAYA Biosciences, Inc. filed an 8-K on October 30, 2026, disclosing that its Compensation Committee granted non-qualified stock options to purchase an aggregate of 99,600 shares to four newly hired employees on October 29, 2026, under its 2023 Employment Inducement Incentive Award Plan.

Key Highlights

  • Aggregate grant size: 99,600 shares of common stock subject to non-qualified stock options, granted to four newly hired employees.
  • Exercise price: $32.89 per share, equal to the closing price of IDEAYA's common stock on The Nasdaq Global Select Market on the date of grant.
  • Grant date: October 29, 2026, as approved by the Compensation Committee of IDEAYA's Board of Directors.
  • Vesting schedule: 25% vests on the first anniversary of the vesting commencement date, with the remaining 75% vesting in equal monthly installments over the following three years.
  • Option term: 10 years, subject to each employee's continued service on each vesting date.
  • Governing plan: IDEAYA Biosciences, Inc. 2023 Employment Inducement Incentive Award Plan, used exclusively for individuals not previously employed by IDEAYA, pursuant to Nasdaq Listing Rule 5635(c)(4).

IDEAYA Biosciences Issues Inducement Options to Four New Hires in October 2026

According to the filing, IDEAYA Biosciences, Inc. (NASDAQ:IDYA) announced that the Compensation Committee of its Board of Directors granted non-qualified stock options covering a total of 99,600 shares of common stock on October 29, 2026. The recipients are four newly hired employees, and the grant was made under the company's 2023 Employment Inducement Incentive Award Plan (2023 Inducement Plan).

The filing states that the 2023 Inducement Plan is used exclusively for equity awards to individuals who were not previously employees of IDEAYA, or who are rejoining following a bona fide period of non-employment, in accordance with Nasdaq Listing Rule 5635(c)(4). The exercise price of $32.89 per share was set equal to the closing price of IDEAYA's common stock on The Nasdaq Global Select Market on the date of grant, as the company disclosed.

The stock options carry a 10-year term. As described in the filing, vesting follows a four-year schedule: 25% of each grant vests on the first anniversary of the vesting commencement date, and the remaining 75% vests in equal monthly installments over the subsequent three years. The filing notes that vesting is conditioned on each employee's continued service to IDEAYA on each applicable vesting date.

What Was Disclosed

IDEAYA Biosciences disclosed the grant of 99,600 inducement stock options to four new employees on October 29, 2026, at an exercise price of $32.89 per share, with a four-year vesting schedule and a 10-year term, under its 2023 Inducement Plan.